Comparative Effects of High-Intensity Interval Training and Continuous Endurance Training Among Prediabetic Patients
NCT07713030
Summary
Prediabetics is a condition where blood sugar levels are normal but not yet high enough to be diagnosed as type 2 diabetes. This phase offers a crucial point for timely intervention to delay or prevent type 2 diabetes. The objective of the study will be to find the effects of high intensity interval and continuous endurance training on glycemic control, BMI, Vo2 Max, pulmonary function and physical activity among prediabetic patients. Study design will be randomized control trial. Total 80 participants will be enrolled in study. The data will be collected from faculty of Riphah International University, Lahore. The study will be completed within 8 months after approval of synopsis. A simple random sampling will be used to assign the groups; group A and group B. Group A will be assigned high intensity interval training and group B will be assigned to continuous training.
Eligibility
Inclusion Criteria: * Sedentary lifestyle (Individuals reporting minimal structured physical activity e.g., \<30 minutes of exercise per week) . * Stable Medical Condition (No history of significant cardiovascular events, uncontrolled hypertension, or other major comorbidities). * Stable Body Weight (Stable body weight with changes less than 3 kg in the past 6 months). Exclusion Criteria: * uncontrolled hypertension * history of heart disease * myocardial infarction * stroke * Use of Specific Medications (Current use of insulin or other medications affecting glucose metabolism or exercise response) * Severe Obesity (Individuals with a BMI ≥ 40 kg/m) * High fasting blood glucose (Fasting blood glucose of \>100mg.dl-1) * Previous history of respiratory problems * Smoking
Conditions4
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07713030